ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 226 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q1 2023. The put-call ratio across all filers is 1.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $30,124 | -22.7% | 845 | 0.0% | 0.00% | -33.3% |
| Q2 2023 | $38,980 | +15.0% | 845 | 0.0% | 0.01% | +20.0% |
| Q1 2023 | $33,885 | -13.4% | 845 | 0.0% | 0.01% | -28.6% |
| Q4 2022 | $39,149 | +11.9% | 845 | 0.0% | 0.01% | 0.0% |
| Q3 2022 | $35,000 | -30.0% | 845 | 0.0% | 0.01% | -30.0% |
| Q2 2022 | $50,000 | -18.0% | 845 | 0.0% | 0.01% | -9.1% |
| Q1 2022 | $61,000 | -14.1% | 845 | 0.0% | 0.01% | -15.4% |
| Q4 2021 | $71,000 | -6.6% | 845 | 0.0% | 0.01% | -13.3% |
| Q3 2021 | $76,000 | -6.2% | 845 | 0.0% | 0.02% | -11.8% |
| Q2 2021 | $81,000 | -25.0% | 845 | -10.6% | 0.02% | -29.2% |
| Q1 2021 | $108,000 | -17.6% | 945 | 0.0% | 0.02% | -20.0% |
| Q4 2020 | $131,000 | +52.3% | 945 | -9.6% | 0.03% | +42.9% |
| Q3 2020 | $86,000 | +4.9% | 1,045 | 0.0% | 0.02% | 0.0% |
| Q2 2020 | $82,000 | +78.3% | 1,045 | 0.0% | 0.02% | +61.5% |
| Q1 2020 | $46,000 | +2.2% | 1,045 | 0.0% | 0.01% | +18.2% |
| Q4 2019 | $45,000 | 0.0% | 1,045 | 0.0% | 0.01% | -8.3% |
| Q3 2019 | $45,000 | -31.8% | 1,045 | 0.0% | 0.01% | -29.4% |
| Q2 2019 | $66,000 | -8.3% | 1,045 | 0.0% | 0.02% | -10.5% |
| Q1 2019 | $72,000 | +60.0% | 1,045 | 0.0% | 0.02% | +58.3% |
| Q4 2018 | $45,000 | -43.8% | 1,045 | 0.0% | 0.01% | -42.9% |
| Q3 2018 | $80,000 | 0.0% | 1,045 | 0.0% | 0.02% | -4.5% |
| Q2 2018 | $80,000 | +50.9% | 1,045 | 0.0% | 0.02% | +46.7% |
| Q1 2018 | $53,000 | +10.4% | 1,045 | 0.0% | 0.02% | +7.1% |
| Q4 2017 | $48,000 | -14.3% | 1,045 | 0.0% | 0.01% | -17.6% |
| Q3 2017 | $56,000 | -13.8% | 1,045 | 0.0% | 0.02% | -19.0% |
| Q2 2017 | $65,000 | +1.6% | 1,045 | +10.6% | 0.02% | 0.0% |
| Q1 2017 | $64,000 | -16.9% | 945 | -13.7% | 0.02% | -22.2% |
| Q4 2016 | $77,000 | -1.3% | 1,095 | 0.0% | 0.03% | +3.8% |
| Q3 2016 | $78,000 | +44.4% | 1,095 | 0.0% | 0.03% | +36.8% |
| Q2 2016 | $54,000 | -21.7% | 1,095 | 0.0% | 0.02% | -24.0% |
| Q1 2016 | $69,000 | -34.9% | 1,095 | +15.9% | 0.02% | -34.2% |
| Q4 2015 | $106,000 | +16.5% | 945 | 0.0% | 0.04% | +8.6% |
| Q3 2015 | $91,000 | -24.2% | 945 | -19.6% | 0.04% | -22.2% |
| Q2 2015 | $120,000 | +12.1% | 1,175 | -32.0% | 0.04% | +9.8% |
| Q1 2015 | $107,000 | +40.8% | 1,728 | 0.0% | 0.04% | +36.7% |
| Q4 2014 | $76,000 | -22.4% | 1,728 | 0.0% | 0.03% | -26.8% |
| Q3 2014 | $98,000 | – | 1,728 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| First Light Asset Management, LLC | 437,512 | $31,772,000 | 2.80% |
| RTW INVESTMENTS, LP | 1,373,284 | $99,728,000 | 2.06% |
| Rock Springs Capital Management LP | 1,028,109 | $74,661,000 | 1.88% |
| Privium Fund Management B.V. | 112,727 | $8,186,000 | 1.81% |
| Avidity Partners Management LP | 869,000 | $63,107,000 | 1.31% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 525,100 | $38,133,000 | 1.16% |
| Boxer Capital, LLC | 200,000 | $14,524,000 | 0.75% |
| SECTOR GAMMA AS | 46,221 | $3,357,000 | 0.73% |
| FEDERATED HERMES, INC. | 3,987,728 | $289,589,000 | 0.65% |
| EMERALD ADVISERS, LLC | 223,952 | $16,263,000 | 0.62% |